Ocular Surface Review
Shining the Slit Lamp on ADCs
ODs can greatly help ovarian cancer patients who are taking this advanced therapeutic agent, specifically Elahere.
03/15/2024
Not So Benign OSD
If your patient isn’t responding to treatment, look beyond the typical forms of ocular surface disease.
11/15/2023
Call the Exterminator
A new eye drop, Xdemvy, shows positive results in wiping out the unusually common condition known as Demodex blepharitis.
09/15/2023
First of its Kind
Miebo now gives us a medication option that targets MGD and evaporative DED.
07/15/2023
Drink Up
Hydrating the whole body—not just the eyes—is key to improving the ocular surface.
05/15/2023
Toxic Work Environment
Be aware of certain glaucoma therapy options that could harm the ocular surface.
03/15/2023
Right Tool for the Job
These small but mighty instruments can help you better perform a number of procedures and will enhance your practice.
02/15/2023
Making the Grade
Studies show promising results for CyclASol, a new medication to treat DED that could be approved next year.
11/15/2022
Revisit a Steroid Alternative
Acthar Gel, an injectable therapy that activates melanocortin pathways, may be a saving grace for some of your patients.
09/15/2022
Power Trio
Three promising new therapeutics look to dramatically change dry eye disease management.
07/15/2022
Upcoming Events
May 2, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Kamran Riaz, MD, and Melissa Barnett, OD
Webinar: 7:00pm ET
Sponsored by Bausch + Lomb
May 17-19, 2024
June 4, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Karl G. Stonecipher, MD, and Jessica Steen, OD
Webinar: 8:00pm ET
Sponsored by Bausch + Lomb
